A set of ~800 largely isogenic deficiency stocks created by FLP-induced recombination between FRT-carrying transgenic insertions; molecularly defined deletion endpoints correspond to initial location of the progenitor insertions. Designed to fill gaps in deletion coverage and breakpoint placement; also used to replace older available deficiencies that have not been molecularly mapped.
Breakpoint based on release 3 sequence coordinate from Thibault et al., 2004, Supplementary Table 3 (FBrf0174228), converted to release 5 coordinate.
Breakpoint from FlyBase's release 5 sequence location of progenitor insertion.
Carries two copies of a mini-w marker.
Exelixis, Inc. determined the insertion site of PBac{WH}f04029 to be Release 3 genomic coordinate 16194176 on the X chromosome. This corresponds to 14D1 on the Release 3 and Release 5 genome maps. The predicted position of P{XP}crld03572 on the Release 5 map is 14F1. Consequently, the cytological breakpoints of Df(1)BSC761 are predicted to be 14D1;14F1.